Opportunities for drug-delivery research in nutraceuticals and functional foods?

Therapeutic Delivery

Volumn 4, Issue 3, 2013, Pages 301-305

  Brayden, David J ^a   Baird, Alan W ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

drug delivery; functional foods; medical foods; milk derived bioactives

Indexed keywords

FATTY ACID; FOOD DERIVED SMALL MOLECULE; MINERAL; NUTRACEUTICAL; PROBIOTIC AGENT; SMALL MOLECULE TRANSPORT AGENT; UNCLASSIFIED DRUG; VITAMIN;

ARTIFICIAL MILK; BIOASSAY; DIET SUPPLEMENTATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULATION; DRUG INDUSTRY; DRUG LEGISLATION; DRUG RESEARCH; EXCIPIENT COMPATIBILITY; FOOD INDUSTRY; FUNCTIONAL FOOD; GOVERNMENT REGULATION; HUMAN; MICROENCAPSULATION; NANOEMULSION; NONHUMAN; NOTE; NUTRITIONAL SCIENCE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL;

EID: 84874589078     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.12.152     Document Type: Note

References (35)

1. Hasler CM, Brown AC. Position of the american dietetic association: functional foods. J. Am. Diet. Assoc. 109, 735-746 (2009).
2. Hasler CM. Regulation of functional foods and nutraceuticals : a global perspective. IFT Press. Blackwell Pub., Chicago, IL, USA (2005).
3. Rein MJ, Renouf M, Cruz-Hernandez C, Actis-Goretta L, Thakkar SK, da Silva Pinto M. Bioavailability of bioactive food compounds: a challenging journey to bioefficacy. Br. J. Clin. Pharmacol. 75(3), 588-602 (2012).
4. Maher S, Brayden DJ. Overcoming poor permeabilities: translating permeation enhancers for oral peptide delivery. Drug Discov. Today Technol. 9(2), e113-e119 (2012).
5. Folz M, van der Pijl PC, Duchateua G. Current in vitro testing of bioactive peptides is not valuable. J. Nutrition 140, 117-118 (2009).
6. Flint AP, Woolliams JA. Precision animal breeding. Philos. Trans. R Soc. Lond. B Biol. Sci. 363, 573-590 (2008).
7. Shah NP. Effects of milk-derived bioactives: an overview. Br. J. Nutr. 84(Suppl. 1), S3-S10 (2000).
8. Zivkovic AM, Barile D. Bovine milk as a source of functional oligosaccharides for improving human health. Adv. Nutr. 2, 284-289 (2011).
9. Siltari A, Kivimäki AS, Ehlers PI, Korpela R, Vapaatalo H. Effects of milk casein derived tripeptides on endothelial enzymes in vitro; a study with synthetic tripeptides. Arzneimittelforschung 62, 477-481 (2012).
10. Turpeinen AM, Ikonen M, Kivimäki AS, Kautiainen H, Vapaatalo H, Korpela R. A spread containing bioactive milk peptides Ile-Pro-Pro and Val-Pro-Pro, and plant sterols has antihypertensive and cholesterol-lowering effects. Food Funct. 3, 621-627 (2012).
11. Seppo L, Jauhiainen T, Poussa T, Korpela R. A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am. J. Clin. Nutr. 77, 326-330 (2003).
12. Foltz M, Cerstiaens A, van Meensel A et al. The angiotensin converting enzyme inhibitory tripeptides Ile-Pro-Pro and Val-Pro-Pro show increasing permeabilities with increasing physiological relevance of absorption models. Peptides 29, 1312-1320 (2008).
13. van der Pijl PC, Kies AK, Ten Have GA, Duchateau GS, Deutz NE. Pharmacokinetics of proline-rich tripeptides in the pig. Peptides 29, 2196-2202 (2008).
14. Satake M, Enjoh M, Nakamura Y et al. Transepithelial transport of the bioactive tripeptide, Val-Pro-Pro, in human intestinal Caco-2 cell monolayers. Biosci. Biotechnol. Biochem. 66, 378-384 (2002).
15. Tuomilehto J, Lindström J, Hyyrynen J et al. Effect of ingesting sour milk fermented using Lactobacillus helveticus bacteria producing tripeptides on blood pressure in subjects with mild hypertension. J. Hum. Hypertens. 18, 795-802 (2004).
16. Kuang SS, Oliveira JC, Crean AM. Microencapsulation as a tool for incorporating bioactive ingredients into food. Crit. Rev. Food Sci. Nutr. 50, 951-968 (2010).
17. Clarke G, Cryan JF, Dinan TG, Quigley EM. Review article: probiotics for the treatment of irritable bowel syndrome focus on lactic acid bacteria. Aliment Pharmacol. Ther. 35, 403-413 (2012).
18. Carroll IM, Andrus JM, Bruno-Bárcena JM, Klaenhammer TR, Hassan HM, Threadgill DS. Anti-inflammatory properties of Lactobacillus gasseri expressing manganese superoxide dismutase using the interleukin 10-deficient mouse model of colitis. Am. J. Physiol. 293, G729-38 (2007).
19. Champagne CP, Fustier P. Microencapsulation for the improved delivery of bioactive compounds into foods. Curr. Opin. Biotechnol. 18, 184-190 (2007).
20. Chandramouli V, Kailasapathy K, Peiris P, Jones M. An improved method of microencapsulation and its evaluation to protect Lactobacillus spp. in simulated gastric conditions. J. Microbiol. Methods 56, 27-35 (2004).
21. Prakash S, Tomaro-Duchesneau C, Saha S, Cantor A. The gut microbiota and human health with an emphasis on the use of microencapsulated cells. J. Biomed. Biotechnol. 2011, 981214 (2011).
22. McClements DJ, Rao J. Food-grade nanoemulsions: formulation, fabrication, properties, performance, biological fate, and potential toxicity. Crit. Rev. Food Sci. Nutr. 51, 285-330 (2011).
23. Schrooyen PMM, van der Meer R, De Kruif CG. Microencapsulation: its application in nutrition. Proc. Nutr. Soc. 60, 475-479 (2001).
24. Shaw LA, McClements DJ, Decker EA. Spray-dried multilayered emulsions as a delivery method for omega-3 fatty acids into food systems. J. Agric. Food Chem. 55, 3112-3119 (2007).
25. Benshitrit RC, Levi CS, Tal SL, Shimoni E, Lesmes U. Development of oral food-grade delivery systems: current knowledge and future challenges. Food Funct. 3, 10-21 (2012).
26. Castelli MC, Wong DF, Friedman K, Riley MG. Pharmacokinetics of oral cyanocobalamin formulated with sodium N-[8-(2-hydroxybenzoyl)amino]caprylate (SNAC): an open-label, randomized, single-dose, parallel-group study in healthy male subjects. Clin. Ther. 33, 934-945 (2011).
27. Riley MG, Castelli MC, Paehler EA. Subchronic oral toxicity of salcaprozate sodium (SNAC) in Sprague-Dawley and Wistar rats. Int. J. Toxicol. 28, 278-293 (2009).
28. Yasuji T, Kondo H, Sako K. The effect of food on the oral bioavailability of drugs: a review of current developments and pharmaceutical technologies for pharmacokinetic control. Ther. Deliv. 3, 81-90 (2012).
29. Brown MJ, Ferruzzi MG, Nguyen ML et al. Carotenoid bioavailability is higher from salads ingested with full-fat than with fat-reduced salad dressings as measured with electrochemical detection. Am. J. Cin. Nutr. 80, 396-403 (2004).
30. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol. Pharm. 4, 807-818 (2007).
31. Mohanty C, Das M, Sahoo SK. Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin. Expert Opin. Drug Deliv. 9, 1347-1364 (2012).
32. Kanwar J, Taskeen M, Mohammad I, Huo C, Chan TH, Dou QP. Recent advances on tea polyphenols. Front Biosci. 4, 111-131 (2012).
33. Zhou K, Raffoul JJ. Potential anticancer properties of grapes. J. Oncology 2012, 803294 (2012).
34. KnappHR, Melly MA. Bactericidal effects of polyunsaturated fatty acids. J. Infect. Dis. 154, 84-94 (1986).
35. Desbois AP, Smith VJ. Antibacterial free fatty acids: activities, mechanisms of action and biotechnological potential. Appl. Microbiol. Biotechnol. 85, 1629-1642 (2010).